is a glp 1 insulin Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 Agonists: Increasing Effective Insulin

J Neurol Sci, 372:78-84

Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R: Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Your body needs to get used to a steady, weekly dosage schedule

In regard to medical therapy before treatment initiation, GLP1 RA initiators more often redeemed prescriptions for mineralocorticoids, betablockers, calcium channel blockers, reninangiotensin system inhibitors, loop diuretics, and thiazides, but less often for acetylsalicylic acids and statins, compared with metformin initiators

Reported injuries in GLP-1 lawsuits range from chronic nausea and vomiting to intestinal obstruction, malnutrition, emergency surgery, and sudden vision loss, with symptom severity typically ranging from temporary digestive complications to permanent impairment

E., Huang, J., et al